Explore IQVIA Laboratories’ Biosciences white paper, “Mass Matters,” to uncover expert insights into LC-MS bioanalysis for type 2 diabetes (T2D) and obesity drug development. Learn how advanced ADME profiling, regulated bioanalytical methods, and high-resolution mass spectrometry (HRMS) are used to overcome complex challenges in peptide-based therapies, support regulatory compliance, and accelerate clinical success.
Download Document